U.S. Physical Therapy Sees Q4 Revenue Growth Slow to 10.5%
U.S. Physical Therapy generated $197.1 million in revenue last quarter, a 17.3% year-on-year increase that narrowly beat estimates. For Q4, revenue growth is projected at 10.5% year-on-year versus 16.6% in the same quarter last year, while analysts maintain forecasts and price target of $105.33 against an $83.53 share price.
1. Last Quarter Revenue Beat
U.S. Physical Therapy reported $197.1 million in revenue last quarter, marking a 17.3% year-on-year increase that narrowly surpassed analysts’ expectations.
2. Q4 Revenue Outlook
Revenue for the quarter ending December 31 is expected to grow 10.5% year-on-year, down from 16.6% growth in the same quarter last year, with analysts reaffirming their estimates ahead of the report.
3. Peer Results and Valuation Context
Peer outpatient care providers delivered mixed Q4 results, with DaVita posting 9.9% revenue growth beating estimates by 3.2% while Select Medical grew 6.4%, topping forecasts by 2.3%. U.S. Physical Therapy shares are down 2.6% over the past month, trading at $83.53 against a $105.33 average analyst target.